Thermo Fisher Scientific announces expiration of HSR waiting period for Dionex acquisition

Editorial Checklist Reviewed

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the expiration of the mandatory, pre-merger waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), relating to its offer to acquire Dionex (NASDAQ: DNEX).

The company is in the process of seeking similar clearances under antitrust laws of other jurisdictions, and anticipates completing the acquisition later in the first quarter of 2011.

Source:

Thermo Fisher Scientific

Posted in: Life Sciences News

Comments (0)

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thermo Fisher Scientific Inc.. (2019, June 19). Thermo Fisher Scientific announces expiration of HSR waiting period for Dionex acquisition. News-Medical. Retrieved on April 25, 2024 from https://www.news-medical.net/news/20110110/Thermo-Fisher-Scientific-announces-expiration-of-HSR-waiting-period-for-Dionex-acquisition.aspx.

  • MLA

    Thermo Fisher Scientific Inc.. "Thermo Fisher Scientific announces expiration of HSR waiting period for Dionex acquisition". News-Medical. 25 April 2024. <https://www.news-medical.net/news/20110110/Thermo-Fisher-Scientific-announces-expiration-of-HSR-waiting-period-for-Dionex-acquisition.aspx>.

  • Chicago

    Thermo Fisher Scientific Inc.. "Thermo Fisher Scientific announces expiration of HSR waiting period for Dionex acquisition". News-Medical. https://www.news-medical.net/news/20110110/Thermo-Fisher-Scientific-announces-expiration-of-HSR-waiting-period-for-Dionex-acquisition.aspx. (accessed April 25, 2024).

  • Harvard

    Thermo Fisher Scientific Inc.. 2019. Thermo Fisher Scientific announces expiration of HSR waiting period for Dionex acquisition. News-Medical, viewed 25 April 2024, https://www.news-medical.net/news/20110110/Thermo-Fisher-Scientific-announces-expiration-of-HSR-waiting-period-for-Dionex-acquisition.aspx.

Suggested Reading

Thermo Scientific MAS Omni Infectious Controls launched to assess the performance of serological assays
Thermo Fisher Scientific and Symphogen extend collaboration to boost drug discovery and development
New Thermo Scientific Neoma Multicollector ICP-MS system delivers reliable isotopic data
Thermo Fisher Scientific launches two breakthrough imaging filters that take cryo-EM to a new level
Thermo Fisher Scientific continues to support the development of COVID-19 vaccines, therapies
Thermo Scientific Smart-Vue Pro Remote Monitoring Solution supports optimal sample safety and integrity
Thermo Fisher announces construction of new cGMP plasmid DNA manufacturing facility
New developments at Evosep to make clinical proteomics 100x more robust and 10x faster

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Trending Stories

More Content from Thermo Fisher Scientific Inc.

See all content from Thermo Fisher Scientific Inc.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Thermo Fisher Scientific launches industry-leading, cGMP-compatible CTS Series Laboratory Equipment